Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 7, 2014; 20(33): 11808-11814
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11808
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11808
Figure 1 Patients treated with anti-tumor necrosis factor agents had significantly longer median time from Crohn’s disease diagnosis to surgery.
TNF: Tumor necrosis factor.
Figure 2 Combination therapy using immunomodulator and anti-tumor necrosis factor agent further extended the median time from Crohn’s disease diagnosis to surgery for patients requiring surgery in years 2005 to 2010 (cohort B).
TNF: Tumor necrosis factor; IM: Immunomodulator.
- Citation: Fu YN, Hong T, Round A, Bressler B. Impact of medical therapy on patients with Crohn’s disease requiring surgical resection. World J Gastroenterol 2014; 20(33): 11808-11814
- URL: https://www.wjgnet.com/1007-9327/full/v20/i33/11808.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i33.11808